Nakamura Y, Sakiyama S, Takenaga K
Division of Biochemistry, Chiba Cancer Center Research Institute, Japan.
Cell Motil Cytoskeleton. 1995;31(4):273-82. doi: 10.1002/cm.970310404.
In mouse fibroblasts, at least five TM isoforms are identified and they can be grouped into the high (TM1, TM2, and TM3) and low molecular weight TM isoforms (TM4 and TM5). Suppression of one of the high molecular weight tropomyosin (TM) isoforms in nonmuscle cells is implicated to be one of the causes for disorganization of actin microfilament bundles and subsequent changes in cell motility and cell shape. In this study, we studied the expression of tropomyosin isoforms in macrophages that exhibit high motility and ability to change cell shape. Two-dimensional gel electrophoresis followed by Western blot analysis using polyclonal anti-TM antiserum revealed that the high molecular weight TM isoforms were lacking in both resident and activated mouse peritoneal macrophages. Analyses of newly synthesized TM isoforms, Northern blot analyses using isoform-specific cDNA probes, and immunostaining with monoclonal anti-TM antibody that recognizes only the high molecular weight TM isoforms also demonstrated that the syntheses of the high molecular weight TM isoforms (TM1, TM2, and TM3) were completely suppressed, whereas the low molecular weight TM isoforms (TM4 and TM5) were expressed in macrophages. These results indicate that macrophages intrinsically lack the high molecular weight TM isoforms. In order to obtain information about cellular localization of the low molecular weight TM isoforms in macrophages, they were immunostained with polyclonal anti-TM antiserum that recognizes both the high and low molecular weight TM isoforms. The results showed that the low molecular weight TM isoforms were co-localized with F-actin in punctate and short fibrous structures. In addition, we performed in situ hybridization analysis to examine localizations of the TM mRNAs in fibroblasts and macrophages. The results showed that TM mRNAs were localized throughout the cytoplasm.
在小鼠成纤维细胞中,至少鉴定出五种原肌球蛋白(TM)异构体,它们可分为高分子量(TM1、TM2和TM3)和低分子量TM异构体(TM4和TM5)。非肌肉细胞中高分子量原肌球蛋白(TM)异构体之一的抑制被认为是肌动蛋白微丝束紊乱以及随后细胞运动性和细胞形态改变的原因之一。在本研究中,我们研究了具有高运动性和细胞形态改变能力的巨噬细胞中原肌球蛋白异构体的表达。二维凝胶电泳后,使用多克隆抗TM抗血清进行蛋白质印迹分析,结果显示常驻和活化的小鼠腹腔巨噬细胞中均缺乏高分子量TM异构体。对新合成的TM异构体的分析、使用异构体特异性cDNA探针的Northern印迹分析以及仅识别高分子量TM异构体的单克隆抗TM抗体的免疫染色也表明,高分子量TM异构体(TM1、TM2和TM3)的合成被完全抑制,而低分子量TM异构体(TM4和TM5)在巨噬细胞中表达。这些结果表明巨噬细胞本质上缺乏高分子量TM异构体。为了获得关于低分子量TM异构体在巨噬细胞中细胞定位的信息,用识别高分子量和低分子量TM异构体的多克隆抗TM抗血清对它们进行免疫染色。结果表明,低分子量TM异构体与F-肌动蛋白共定位在点状和短纤维结构中。此外,我们进行了原位杂交分析,以检查TM mRNA在成纤维细胞和巨噬细胞中的定位。结果表明TM mRNA定位于整个细胞质中。